Supernus Pharmaceuticals Ownership | Who Owns Supernus Pharmaceuticals?
Supernus Pharmaceuticals Ownership Summary
Supernus Pharmaceuticals is owned by 105.63% institutional investors, 4.87% insiders. Blackrock is the largest institutional shareholder, holding 18.90% of SUPN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.92% of its assets in Supernus Pharmaceuticals shares.
SUPN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Supernus Pharmaceuticals | 105.63% | 4.87% | -10.50% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 2774.71% | 11.85% | -2686.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 10.39M | 18.90% | $278.00M |
| Blackrock funding, inc. /de | 10.00M | 18.13% | $361.53M |
| Vanguard group | 6.15M | 11.15% | $222.41M |
| Armistice capital | 4.84M | 8.77% | $174.87M |
| Dimensional fund advisors lp | 2.88M | 5.22% | $104.09M |
| Macquarie group | 2.63M | 4.77% | $95.06M |
| State street | 2.16M | 3.94% | $57.88M |
| Polar capital | 1.94M | 3.53% | $51.91M |
| Stephens investment management group | 1.75M | 3.18% | $63.35M |
| Renaissance | 1.60M | 2.90% | $57.81M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ashford capital management | 711.89K | 2.57% | $19.04M |
| Armistice capital | 4.84M | 2.39% | $174.87M |
| Third avenue management | 189.49K | 1.33% | $6.85M |
| S&t bank/pa | 112.19K | 1.29% | $4.06M |
| Aristotle capital boston | 1.20M | 1.08% | $32.18M |
| Rice hall james & associates | 528.35K | 1.05% | $19.10M |
| Tributary capital management | 343.96K | 0.96% | $12.44M |
| Bruce | 82.11K | 0.95% | $2.97M |
| Stephens investment management group | 1.75M | 0.85% | $63.35M |
| Bridge city capital | 82.28K | 0.74% | $2.20M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bnp paribas arbitrage, snc | 292.63K | 0.01% | 208.55K |
| Great lakes advisors | 169.56K | 0.05% | 169.56K |
| D. e. shaw | 545.66K | 0.01% | 136.87K |
| Cubist systematic strategies | 139.52K | 0.03% | 126.16K |
| Norges bank | 125.55K | 0.00% | 125.55K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Woodline partners lp | - | - | -423.83K |
| Armistice capital | 4.84M | 2.39% | -260.00K |
| Millennium management | 30.47K | 0.00% | -222.27K |
| Schroder investment management group | 298.66K | 0.01% | -216.64K |
| Raymond james financial | - | - | -189.36K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Great lakes advisors | 169.56K | 0.05% | 169.56K | $6.13M |
| Norges bank | 125.55K | 0.00% | 125.55K | $4.54M |
| Wedge capital management l l p/nc | 53.33K | 0.03% | 53.33K | $1.93M |
| Empowered funds | 41.43K | 0.02% | 41.43K | $1.50M |
| Jefferies financial group | 24.60K | 0.01% | 24.60K | $889.54K |
Sold Out
| Holder | Change |
|---|---|
| Claris advisors, llc / mo / | -1.00 |
| Mendota financial group | -5.00 |
| Cva family office | -14.00 |
| Cornerstone planning group | -15.00 |
| Continuum advisory | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 286 | -2.72% | 59,007,517 | -0.81% | 105 | 0.91% | 144 | -1.37% | 93 | -2.11% |
| Dec 31, 2024 | 137 | -49.63% | 29,073,367 | -51.31% | 52 | 0.45% | 69 | -48.51% | 37 | -58.89% |
| Sep 30, 2024 | 272 | 11.02% | 59,712,047 | 2.23% | 108 | 0.96% | 134 | 15.52% | 90 | 12.50% |
| Jun 30, 2024 | 245 | -3.54% | 58,410,943 | 3.44% | 106 | 1.00% | 116 | 9.43% | 80 | -15.79% |
| Mar 31, 2024 | 254 | 2.42% | 56,466,578 | -1.13% | 103 | 0.94% | 106 | -10.17% | 95 | 7.95% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3.31M | 5.92% | -1.87K |
| Macquarie Small Cap Core I | 2.05M | 3.68% | 58.38K |
| Delaware Small Cap Core I | 2.00M | 3.62% | -12.37K |
| Vanguard Total Stock Mkt Idx Inv | 1.71M | 3.05% | 34.57K |
| Vanguard US Total Market Shares ETF | 1.68M | 3.00% | 1.91K |
| Vanguard Small Cap Index | 1.33M | 2.38% | 6.21K |
| iShares Russell 2000 ETF | 1.29M | 2.30% | 630.00 |
| Stephens SMID Select Growth | 1.24M | 2.22% | - |
| Polar Capital Biotech S Inc | 1.20M | 2.14% | -50.00K |
| Vanguard Explorer Inv | 995.69K | 1.78% | 41.81K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 21, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | $36.29K |
| Feb 04, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $376.24K |
| Jan 28, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $27.73K |
| Dec 03, 2024 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $467.49K |
| Nov 11, 2024 | NEWHALL CHARLES W III | - | Sell | $387.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 1 |
| 2024 Q1 | - | 8 |
SUPN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools